高偉(01415.HK)續升13%交投持續活躍 料全年溢利明顯改善
高偉電子(01415.HK)發盈喜料全年溢利明顯改善,該股延續過去兩天強勢,今早進一步高見1.87元,創逾七個月高,現造1.75元,逆同業續升13%,成交續增至1,759萬股,創逾八個月高,涉資3,156萬元。
高偉發盈喜指,受惠相機模組銷售額上升、生產量改善及有效成本管理帶動,預計截至12月止之全年溢利將明顯改善。該公司2018年全年純利按年倒退近50%至1,391萬美元;2019年上半年扭虧轉賺近82萬美元(上年同期蝕247萬美元)。(sz/t)~
阿思達克財經新聞
網址: www.aastocks.com
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.